Skip to content
10-Q

Quarterly Report

LA JOLLA PHARMACEUTICAL CO

0001564590-21-025325

← back to feed
Filed
May 7, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Apr 3, 2021 27.45M sh
Current Liabilities Q1 2021 · Mar 31, 2021 $11.71M
Current Liabilities Q1 2021 · Dec 31, 2020 $12.34M
Total Liabilities Q1 2021 · Mar 31, 2021 $161.91M
Total Liabilities Q1 2021 · Dec 31, 2020 $160.33M
Current Assets Q1 2021 · Mar 31, 2021 $54.27M
Current Assets Q1 2021 · Dec 31, 2020 $36.46M
Total Assets Q1 2021 · Mar 31, 2021 $89.59M
Total Assets Q1 2021 · Dec 31, 2020 $72.24M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $21.22M
Cash And Equivalents Q1 2021 · Mar 31, 2020 $77.22M
Shares Diluted Q1 2021 · Mar 31, 2020 27.24M sh
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$12.25M
Stockholders Equity Q1 2021 · Mar 31, 2020 −$61.67M
Stockholders Equity Q1 2021 · Dec 31, 2019 −$55.99M
Eps Diluted Q1 2021 · Mar 31, 2020 −$0.32
Eps Basic Q1 2021 · Mar 31, 2020 −$0.32
Sga Expense Q1 2021 · Mar 31, 2020 $8.15M
Rd Expense Q1 2021 · Mar 31, 2020 $9.18M
Net Income Q1 2021 · Mar 31, 2020 −$8.59M
Operating Income Q1 2021 · Mar 31, 2020 −$10.46M
Revenue Q1 2021 · Mar 31, 2020 $7.59M